Market Vectors® Pharmaceutical ETF (PPH)

Delayed Data
As of 3:59pm ET
 -1.65 / -2.28%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors ® US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for Market Vectors® Pharmaceutical ETF.


1 month0.00% 3 years+27.54%
3 months+3.74% 5 years--
1 year+18.46% Since inception+24.83%
Data through 06/27/2015

Quote Details

Previous close$72.40
Open day’s range70.68 – 71.90
Net asset value (NAV)72.37 (06/26/2015)
Daily volume60,976
Average volume (3 months)80,240
Data as of 3:59pm ET, 06/29/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+22.89%
Expense Gross exp ratio0.43%0.47%
Risk 5 year sharpe ratio--1.68
Net assets$374.7M$1.9B
Average market cap$101.9B$38.6B
Average P/E24.224.7
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
NVS Novartis9.38%
JNJ Johnson & Johnson8.16%
PFE Pfizer6.59%
NVO Novo Nordisk5.73%
-- 5.15%
MRK Merck5.02%
ABBV AbbVie4.93%
AGN Allergan4.89%
SNY Sanofi4.87%
LLY Eli Lilly and Co4.81%

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers